Literature DB >> 22644875

The risk of hematoma following extensive electromyography of the lumbar paraspinal muscles.

Zachary London1, Douglas J Quint, Andrew J Haig, Karen S J Yamakawa.   

Abstract

INTRODUCTION: The purpose of this study is to provide a controlled trial looking at the risk of paraspinal hematoma formation following extensive paraspinal muscle electromyography.
METHODS: 54 subjects ages 55-80 underwent MRI of the lumbar spine before or shortly after electromyography using the paraspinal mapping technique. A neuroradiologist, blinded to the temporal relationship between the EMG and MRI, reviewed the MRIs to look for hematomas in or around the paraspinal muscles.
RESULTS: Two MRIs demonstrated definite paraspinal hematomas, while 10 were found to have possible hematomas. All hematomas were < 15 mm, and none were close to any neural structures. There was no relationship between MRI evidence of hematoma and either the timing of the EMG or the use of aspirin or other nonsteroidal anti-inflammatory drugs.
CONCLUSIONS: Paraspinal electromyography can be considered safe in the general population and those taking nonsteroidal anti-inflammatory drugs.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22644875      PMCID: PMC3374880          DOI: 10.1002/mus.23288

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  13 in total

1.  Large paraspinal and iliopsoas muscle hematomas.

Authors:  Yasuhiko Baba; Kenneth Hentschel; William D Freeman; Daniel F Broderick; Zbigniew K Wszolek
Journal:  Arch Neurol       Date:  2005-08

2.  Survey of electrodiagnostic laboratories regarding hemorrhagic complications from needle electromyography.

Authors:  Kirsten L Gruis; Ann A Little; Valerie A Zebarah; James W Albers
Journal:  Muscle Nerve       Date:  2006-09       Impact factor: 3.217

3.  Paraspinal muscle hematoma after electromyography.

Authors:  J B Caress; S B Rutkove; M Carlin; S Khoshbin; D C Preston
Journal:  Neurology       Date:  1996-07       Impact factor: 9.910

4.  Paraspinal electromyography in high lumbar and thoracic lesions.

Authors:  A J Haig; K Yamakawa; D M Hudson
Journal:  Am J Phys Med Rehabil       Date:  2000 Jul-Aug       Impact factor: 2.159

5.  Identifying lumbosacral radiculopathies: an optimal electromyographic screen.

Authors:  T R Dillingham; T D Lauder; M Andary; S Kumar; L E Pezzin; R T Stephens; S Shannon
Journal:  Am J Phys Med Rehabil       Date:  2000 Nov-Dec       Impact factor: 2.159

6.  Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study.

Authors:  P Petersen; G Boysen; J Godtfredsen; E D Andersen; B Andersen
Journal:  Lancet       Date:  1989-01-28       Impact factor: 79.321

7.  Risk of hematoma following needle electromyography of the paraspinal muscles.

Authors:  Jon T Gertken; Christopher H Hunt; Nataly I Montes Chinea; Jonathan M Morris; Eric J Sorenson; Andrea J Boon
Journal:  Muscle Nerve       Date:  2011-09       Impact factor: 3.217

8.  Synovial cysts of the lumbar facet joints in a symptomatic population: prevalence on magnetic resonance imaging.

Authors:  Anthony J Doyle; Mervyn Merrilees
Journal:  Spine (Phila Pa 1976)       Date:  2004-04-15       Impact factor: 3.468

9.  Clinical experience with paraspinal mapping. II: A simplified technique that eliminates three-fourths of needle insertions.

Authors:  A J Haig
Journal:  Arch Phys Med Rehabil       Date:  1997-11       Impact factor: 3.966

10.  Subcutaneous hemorrhage in a patient receiving anticoagulant therapy: an unusual EMG complication.

Authors:  M L Butler; R W Dewan
Journal:  Arch Phys Med Rehabil       Date:  1984-11       Impact factor: 3.966

View more
  2 in total

1.  Knowledge of electromyography (EMG) in patients undergoing EMG examinations.

Authors:  Mauro Mondelli; Alessandro Aretini; Giuseppe Greco
Journal:  Funct Neurol       Date:  2014 Jul-Sep

Review 2.  Dry Needling and Antithrombotic Drugs.

Authors:  María Muñoz; Jan Dommerholt; Sara Pérez-Palomares; Pablo Herrero; Sandra Calvo
Journal:  Pain Res Manag       Date:  2022-01-07       Impact factor: 3.037

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.